Table 3.
Univariate analysis for factors predicting anastomotic leakage after TE
| Anastomotic leakage | P-value | ||
|---|---|---|---|
| Negative (n = 58) | Positive (n = 17) | ||
| Age (years) | 62.3 ± 7.8 | 57.8 ± 8.3 | N.S. |
| Gender (Male, Female) | 43, 15 | 14, 3 | N.S. |
| BMI | 21.3 ± 2.7 | 21.1 ± 2.8 | N.S. |
| Preoperative chemotherapy | 25 (43.1%) | 9 (52.9%) | N.S. |
| TNM Stage (I, II, III, IV) | 22, 13, 20, 3 | 6, 6, 4, 1 | N.S. |
| Total operation time (min) | 608 ± 112 | 594 ± 122 | N.S. |
| Operation time of thoracic surgery (min) | 338 ± 76 | 305 ± 60 | N.S. |
| Blood loss (g) | 380 (290–608) | 350 (235–615) | N.S. |
| Blood Transfusion | 6 (10.3%) | 1 (5.9%) | N.S. |
| 3-field lymph node dissection | 15 (25.9%) | 8 (47.1%) | N.S. |
| Paroxysmal atrial fibrillation | 10 (17.2%) | 3 (17.7%) | N.S. |
| Vasopressor agents | 7 (12.1%) | 1 (5.9%) | N.S. |
| WBC (10^3/μl) at 1POD | 9.7 (8.2–12.8) | 8.9 (7.0–11.5) | N.S. |
| CRP (10^4 μg/L) at 1POD | 8.7 ± 2.4 | 10.5 ± 2.0 | < 0.01 |
| Lactic acid (mmol/L) at 1POD | 1.5 (1.1–2.0) | 2.0 (0.7–2.6) | N.S. |
| CPK (IU/L) at 1POD | 919.5 (629–1400) | 1232 (683–2177) | < 0.05 |
| Postoperative hospital stay (days) | 22 (19–28) | 42 (30–47) | < 0.01 |